| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Dec 11, 2025 | GLAUKOS Corp | Director | Sell | 20.0 | -5,000 | -12.53% | ✗ | $536.4K |
| Dec 20, 2024 | Dec 23, 2024 | GLAUKOS Corp | Director | Sell | 10.0 | -10,000 | -23.62% | ✓ | $1.5M |
| Dec 11, 2024 | Dec 13, 2024 | GLAUKOS Corp | Director | Sell | 20.0 | -2,000 | -5.82% | ✗ | $288K |
| Sep 9, 2024 | Sep 11, 2024 | GLAUKOS Corp | Director | Sell | 20.0 | -3,000 | -8.49% | ✗ | $392K |
| May 30, 2024 | Jun 3, 2024 | GLAUKOS Corp | Director | Sell | 20.0 | -3,284 | -9.22% | ✗ | $560K |
| Mar 6, 2024 | Mar 8, 2024 | GLAUKOS Corp | Director | Sell | 17.5 | -13,347 | -30.36% | ✗ | $1.2M |
| Feb 27, 2024 | Feb 29, 2024 | GLAUKOS Corp | Director | Sell | 20.0 | -8,000 | -17.03% | ✗ | $736K |
| Aug 4, 2023 | Aug 8, 2023 | GLAUKOS Corp | Director | Sell | 20.0 | -10,000 | -25.17% | ✗ | $745.6K |
| Aug 4, 2022 | Aug 8, 2022 | GLAUKOS Corp | Director | Sell | 22.5 | -318,234 | -88.52% | ✗ | $178.2K |
| Feb 23, 2022 | Feb 25, 2022 | Doximity, Inc. | Director | Sell | 17.5 | -30,000 | -6.25% | ✗ | $1.7M |
| Dec 7, 2021 | Dec 8, 2021 | Doximity, Inc. | Director | Sell | 20.0 | -14,892 | -3.01% | ✗ | $932.2K |
| Dec 2, 2021 | Dec 6, 2021 | Doximity, Inc. | Director | Sell | 22.5 | -4,052,222 | -89.12% | ✗ | $131.6K |
| Nov 19, 2021 | Nov 23, 2021 | Braze, Inc. | 10% Owner | Sell | 15.0 | -5,654,219 | -100.00% | ✗ | $69.4M |
| Jun 28, 2021 | Jun 28, 2021 | Doximity, Inc. | Director | Sell | 15.0 | -4,289,250 | -100.00% | ✗ | $105.4M |
| Sep 25, 2020 | Oct 2, 2020 | PMV Pharmaceuticals, Inc. | 10% Owner | Buy | 97.5 | +55,555 | 100.00% | ✗ | $1000K |
| Sep 25, 2020 | Sep 29, 2020 | PMV Pharmaceuticals, Inc. | 10% Owner | Buy | 97.5 | +55,000 | 100.00% | ✗ | $990K |
| Aug 6, 2019 | Aug 8, 2019 | Vyome Holdings, Inc | 10% Owner | Buy | 90.0 | +25,000 | 7.04% | ✗ | $100K |
| Aug 29, 2018 | Aug 31, 2018 | GLAUKOS Corp | Director | Sell | 15.0 | -1,017,083 | -99.22% | ✗ | $30.4M |
| Aug 23, 2018 | Aug 27, 2018 | Vyome Holdings, Inc | 10% Owner | Buy | 100.0 | +1,098,901 | 44.79% | ✗ | $2M |
| Aug 9, 2018 | Aug 13, 2018 | Venus Concept Inc. | Director | Buy | 100.0 | +2,000,000 | 59.60% | ✗ | $3M |
| Apr 14, 2015 | Apr 14, 2015 | KalVista Pharmaceuticals, Inc. | 10% Owner | Buy | 100.0 | +810,000 | 21.26% | ✗ | $4.1M |